Nouscom's Personalized Neoantigen Cancer Immunotherapy NOUS-

/PRNewswire/ -- Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized immunotherapies, today announced interim data from...

Related Keywords

Ankara , Turkey , Switzerland , Eleanor Perkin , Prnewswire Nouscom , Rick Davis , Oliver Bechter , Sylvie Berrebi , Bristol Myers Squibb , Sven Gogov , Linkedin , Society For Immunotherapy Of Cancer , Leuven Cancer Institute Belgium , Janssen Research Development , Annual Meeting , Principal Investigator , General Medical Oncology , Leuven Cancer Institute , Chief Medical Officer , Presentation Details , Novel Personalized Viral Based , Interim Results , First Subjects , Modified Vaccinia Ankara , Vaccine Encoded Neontigens Unrestricted Selection , Novel Selection Approach , Lynch Syndrome Carriers , Myeloproliferative Neoplasms , Janssen Research , Nouscom ,